CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- POSASR Other POSASR
- 8-K Event Results of operations · Executive or director change
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event New debt or obligation
- 8-K Event Material agreement
- 8-K Event Executive or director change · Other events
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, Head of R&D sold 4,342 shares at an average $4.49 ($19,497)
- 4 Open-market sale President and CEO sold 15,591 shares at $4.49 ($70,004)
- 4 Open-market sale SVP, GC & Secretary sold 3,612 shares at $4.49 ($16,218)
- 4 Open-market sale Chief Financial Officer sold 6,255 shares at an average $4.49 ($28,086)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 16 of 57 · 1,133 filings